<DOC>
	<DOCNO>NCT01995656</DOCNO>
	<brief_summary>The main purpose study evaluate safety tolerability study drug know LY3108743 healthy participant participant type 2 diabetes . The study also investigate LY3108743 affect level blood sugar naturally occur substance ( e.g . hormone control way sugar use ) body , much study drug get blood stream , long take body get rid . Information side effect may occur collect . The study expect last approximately 7 8 week participant . The study 3 part . Participants may enroll one part .</brief_summary>
	<brief_title>A Study LY3108743 Healthy Participants Participants With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Must male , female become pregnant , either healthy participant , type 2 diabetes Have body mass index ( BMI ) 18.5 40.0 kilogram per square meter ( kg/m^2 ) , inclusive , screen Have normal blood pressure Participants diabetes must take antihyperglycemic medication exception metformin . If metformin , participant must stable treatment regimen least 4 week prior screen Participants diabetes must hemoglobin A1c ( HbA1c ) level 6 11 % , inclusive , screen Have previously complete withdrawn study Have use health problem laboratory test result electrocardiogram ( ECG ) reading , opinion doctor , could make unsafe participate could interfere understand result study</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>